|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/343 | (2006.01) |
| A61K 31/4965 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/5575 | (2006.01) | ||
| A61K 31/5578 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 3300729 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17191033.4 |
| Date of filing the European patent application | 2009-08-12 | |
| (97) | Date of publication of the European application | 2018-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation | 2020-01-10 |
| (30) | Number | Date | Country code |
| PCT/IB2008/0532 | 2008-08-13 | WO |
| (72) |
CLOZEL, Martine, CH
|
| (73) |
Actelion Pharmaceuticals Ltd,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapinės kompozicijos, apimančios macitentaną |
| THERAPEUTIC COMPOSITIONS CONTAINING MACITENTAN |
| Payment date | Validity (years) | Amount | |
| 2024-07-08 | 16 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-09-18 |